跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,859 条关于
“Zelluna ASA”
全部
4,859
临床试验
3,257
药物
575
机构
545
资讯
482
2个月前
Zelluna Doses First Patient with World's First MAGE-A4-Targeting TCR-NK Therapy in Phase 1 Solid Tumour Trial
2个月前
Zelluna Closes UV1 Cancer Vaccine Programme After Fifth Phase II Trial Failure in Ovarian Cancer
11个月前
Zelluna Receives MHRA Approval for First-in-Human Trial of Novel TCR-NK Cell Therapy ZI-MA4-1
9个月前
Zelluna Achieves Manufacturing Milestone for First-in-Class MAGE-A4 TCR-NK Cell Therapy
2个月前
VIVEbiotech and Zelluna Advance Off-the-Shelf TCR-NK Cell Therapy for Solid Tumors Toward 2026 Clinical Trials
去年
Ultimovacs Announces Q3 2024 Results and Strategic Update
去年
Ultimovacs ASA Provides Update on Clinical Trials and Financial Strategy
去年
BerGenBio's AXL Inhibitor Shows Promise in STK11-Mutated Lung Cancer, Faces Leadership Transition
去年
BerGenBio's AXL Inhibitor Receives FDA Fast Track for STK11-Mutated Cancers Amidst Leadership Transition
去年
Vertex's Non-Opioid Suzetrigine Shows Promise in Phase 3 Acute Pain Trials
第 1 页,共 49 页
上一页
下一页